Citation: J. Adolfsson et al., DEFERRED TREATMENT OF CLINICALLY LOCALIZED LOW-GRADE PROSTATE-CANCER - ACTUAL 10 YEARS AND PROJECTED 15 YEARS FOLLOW-UP OF THE KAROLINSKA SERIES, The Journal of urology, 159(5), 1998, pp. 965-965
Citation: J. Adolfsson et al., DEFERRED TREATMENT OF CLINICALLY LOCALIZED LOW-GRADE PROSTATE-CANCER - ACTUAL 10-YEAR AND PROJECTED 15-YEAR FOLLOW-UP OF THE KAROLINSKA SERIES, Urology, 50(5), 1997, pp. 722-726
Authors:
HALL R
HEDLUND PO
ACKERMANN R
BRUCHOVSKY N
DALESIO O
DEBRUYNE F
MURPHY GP
PARMAR MKB
PAVONEMACALUSO M
RUUTU M
SMITH P
Citation: R. Hall et al., EVALUATION AND FOLLOW-UP OF PATIENTS WITH N1-3 M0 OR NXM1 PROSTATE-CANCER IN PHASE-III TRIALS, Urology, 49(4A), 1997, pp. 39-45
Authors:
HEDLUND PO
JACOBSSON H
VAAGE S
HAHNE B
SANDIN T
KONTTURI M
NORDLE O
ESPOSTI P
PERMI J
ALFTHAN O
GIDLUND O
HAGGMAN M
JOHANSSON JE
LUNDGREN R
RASMUSSEN F
TVETER K
HAUKAAS S
Citation: Po. Hedlund et al., TREATMENT OF HIGH-GRADE, HIGH-STAGE PROSTATE-CANCER WITH ESTRAMUSTINEPHOSPHATE OR DIETHYLSTILBESTROL - A DOUBLE-BLIND-STUDY, Scandinavian journal of urology and nephrology, 31(2), 1997, pp. 167-172
Authors:
STEGE R
CARLSTROM K
HEDLUND PO
POUSETTE A
VONSCHOULTZ B
HENRIKSSON P
Citation: R. Stege et al., INTRAMUSCULAR DEPOT ESTROGEN (ESTRADURIN( R)) IN THE TREATMENT OF PATIENTS WITH PROSTATIC-CARCINOMA HISTORY, MECHANISMS, EFFECTS AND CURRENT CLINICAL STATUS, Der Urologe, 34(5), 1995, pp. 398-403
Citation: Gd. Chisholm et Po. Hedlund, THE TNM SYSTEM OF 1992 COMMENTS FROM THE TNM WORKING GROUP, Scandinavian journal of urology and nephrology, 1994, pp. 107-114
Authors:
ADOLFSSON J
RONSTROM L
LOWHAGEN T
CARSTENSEN J
HEDLUND PO
Citation: J. Adolfsson et al., DEFERRED TREATMENT OF CLINICALLY LOCALIZED LOW-GRADE PROSTATE-CANCER - THE EXPERIENCE FROM A PROSPECTIVE SERIES AT THE KAROLINSKA-HOSPITAL, The Journal of urology, 152(5), 1994, pp. 1757-1760